Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

3501. Cost-effectiveness analysis of strategies for colorectal cancer screening in Japan

Cost-effectiveness analysis of strategies for colorectal cancer screening in Japan Cost-effectiveness analysis of strategies for colorectal cancer screening in Japan Cost-effectiveness analysis of strategies for colorectal cancer screening in Japan Shimbo T, Glick H A, Eisenberg J M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed (...) by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Several screening strategies for colorectal cancer (CRC) were examined. These were based on the combination of biochemical faecal occult blood testing (F), immunological faecal occult blood testing (IF), barium enema (B), colonoscopy (C) and sigmoidoscopy (S). The strategies were as follows. Strategy 1 was F-F-B-C. F was performed annually, followed by second F if the first results was positive

1994 NHS Economic Evaluation Database.

3502. Should relatives of patients with colorectal cancer be screened: a critical review of the literature

Should relatives of patients with colorectal cancer be screened: a critical review of the literature Should relatives of patients with colorectal cancer be screened: a critical review of the literature Should relatives of patients with colorectal cancer be screened: a critical review of the literature Brewer D A, Fung C L, Chapuis P H, Bokey E L Authors' objectives To assess whether there should be index screening and surveillance of relatives of patients with colorectal cancer (CRC). Searching (...) The authors searched Index Medicus and MEDLINE (up to January 1993) for English language publications (search terms not stated). Abstracts and studies that involved only members of autosomal dominant inherited CRC syndrome families were excluded. Study selection Study designs of evaluations included in the review Studies of relatives of patients with famililal and/or common discrete (sporadic) CRC were included. Specific interventions included in the review Index screening through the use of fecal occult

1994 DARE.

3503. Choice of serum markers in antenatal screening for Downs's syndrome

Choice of serum markers in antenatal screening for Downs's syndrome Choice of serum markers in antenatal screening for Downs's syndrome Choice of serum markers in antenatal screening for Downs's syndrome Wald N J, Watt H C Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study (...) and the conclusions drawn. Health technology Screening for Down's syndrome using: a) double test (alpha fetoprotein (AFP) and human chorionic gonadotropin (hCG)); b) triple test (AFP, unconjugated oestriol (uE(3)), hCG); c) quadruple test (AFP, uE(3), the freed alpha subunit of hCG, and either total or free beta-hCG). Type of intervention Screening Economic study type Cost-effectiveness analysis. Study population A hypothetical group of pregnant women. Setting A hospital outpatient maternity care centre

1994 NHS Economic Evaluation Database.

3504. Incremental cost-effectiveness of incorporating oestriol evaluation in Down syndrome screening programmes

Incremental cost-effectiveness of incorporating oestriol evaluation in Down syndrome screening programmes Incremental cost-effectiveness of incorporating oestriol evaluation in Down syndrome screening programmes Incremental cost-effectiveness of incorporating oestriol evaluation in Down syndrome screening programmes Ganiats T G, Halverson A L, Bogart M H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains (...) a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Prenatal screening tests for Down Syndrome (DS). In particular the use of the 'Double test'- a combination of two maternal blood tests, human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP), with maternal age-related risk, and the 'Triple test'- a combination of three maternal blood tests, unconjugated oestriol (uE3

1994 NHS Economic Evaluation Database.

3505. The cost effectiveness of combined rapid tests (Multistix) in screening for urinary tract infections

The cost effectiveness of combined rapid tests (Multistix) in screening for urinary tract infections The cost effectiveness of combined rapid tests (Multistix) in screening for urinary tract infections The cost effectiveness of combined rapid tests (Multistix) in screening for urinary tract infections Fowlis G A, Waters J, Williams G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Use of combined rapid tests (Multistix) in screening for urinary tract infections. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Urology outpatients and renal transplant patients. Setting The economic study was carried out at a hospital in London, UK. Dates to which data relate Not given. Source

1994 NHS Economic Evaluation Database.

3506. A cost-benefit analysis of two mass screening strategies for albuminuria in diabetic patients

A cost-benefit analysis of two mass screening strategies for albuminuria in diabetic patients A cost-benefit analysis of two mass screening strategies for albuminuria in diabetic patients A cost-benefit analysis of two mass screening strategies for albuminuria in diabetic patients Faronato P, de Bigontina G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The quantitative dipstick method (Micral Test, Boehringer Mannheim, Mannheim, Germany) for albuminuria screening in a diabetic population. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Diabetic subjects both insulin and non-insulin dependant. Setting Secondary care institutions: departments of diabetology in two hospitals

1994 NHS Economic Evaluation Database.

3507. Cost-effectiveness of screening for microalbuminuria using immunochemical dipstick tests or laboratory assays in diabetic patients

Cost-effectiveness of screening for microalbuminuria using immunochemical dipstick tests or laboratory assays in diabetic patients Cost-effectiveness of screening for microalbuminuria using immunochemical dipstick tests or laboratory assays in diabetic patients Cost-effectiveness of screening for microalbuminuria using immunochemical dipstick tests or laboratory assays in diabetic patients Le Floch, J P, Charles, M A, Philippon, C, Perlemuter, L Record Status This is a critical abstract (...) of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology A traditional laboratory assay versus a laboratory assay only in the case of a positive dipstick result to perform a screening for microalbuminuria. Type of intervention Secondary prevention Economic study type Cost-utility analysis

1994 NHS Economic Evaluation Database.

3508. Screening for prostate cancer: a decision analytic view

Screening for prostate cancer: a decision analytic view Screening for prostate cancer: a decision analytic view Screening for prostate cancer: a decision analytic view Krahn M D, Mahoney J E, Eckman M H, Trachtenberg J, Pauker S G, Detsky A S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. Health technology Screening for prostate cancer with prostate-specific antigen (PSA), transrectal ultrasound (TRUS) and digital rectal examination (DRE). Type of intervention Screening/secondary prevention. Economic study type Cost-utility analysis. Study population Cohorts of men between the ages of 50 and 70. Setting Medical centre. The economic study was carried out in Ontario (Canada). Dates to which data relate Dates for effectiveness and resource

1994 NHS Economic Evaluation Database.

3509. An economic appraisal of two strategies in geriatric screening

An economic appraisal of two strategies in geriatric screening An economic appraisal of two strategies in geriatric screening An economic appraisal of two strategies in geriatric screening Johansen G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions (...) drawn. Health technology Screening to identify previously unreported needs for geriatric care. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Individuals over 70 years of age, from a coastal community who were not admitted to a hospital or nursing home. Most of the study population werepreviously associated with the fishing industry and educated only to primary school level. Setting Healthcare clinic/community. The economic study was carried out

1994 NHS Economic Evaluation Database.

3510. Screening for childhood lead poisoning: a cost-minimization analysis

Screening for childhood lead poisoning: a cost-minimization analysis Screening for childhood lead poisoning: a cost-minimization analysis Screening for childhood lead poisoning: a cost-minimization analysis Glotzer D E, Bauchner H, Freedberg K A, Palfrey S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical (...) assessment on the reliability of the study and the conclusions drawn. Health technology Screening strategies for childhood lead poisoning: (1) venipuncture; (2) capillary specimen, with venipuncture confirmation; and (3) stratification by risk, with venipuncture for high-risk children and capillary sample for low-risk children. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Children under the age of 6 years. Setting Primary care. The economic study

1994 NHS Economic Evaluation Database.

3511. Small, blue collar work site hypertension screening: a cost effectiveness study

Small, blue collar work site hypertension screening: a cost effectiveness study Small, blue collar work site hypertension screening: a cost effectiveness study Small, blue collar work site hypertension screening: a cost effectiveness study Ellis E, Koblin W, Irvine M J, Legare J, Logan A G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions (...) followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology One-stage versus two-stage screening for hypertension. One-stage screening consists of a single blood pressure measurement and those with a diastolic blood pressure (DBP) of 90-99 mmHg and already on medication or DBP of 100-114 mmHg were advised to contact their physician within one month. Two-stage screening consisted of two screening tests two weeks apart, with those of high DBP

1994 NHS Economic Evaluation Database.

3512. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Full Text available with Trip Pro

Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. To examine the relation between the use of aspirin and non-steroidal anti-inflammatory drugs and the presence of asymptomatic colorectal adenomas.Case-control study of subjects participating in a randomised controlled trial of faecal occult blood screening for colorectal cancer. Data on analgesics and other

1993 BMJ Controlled trial quality: uncertain

3513. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. Full Text available with Trip Pro

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. Although tests for occult blood in the feces are widely used to screen for colorectal cancers, there is no conclusive evidence that they reduce mortality from this cause. We evaluated a fecal occult-blood test in a randomized trial and documented its effectiveness.We randomly assigned 46,551 participants 50 to 80 years of age to screening for colorectal cancer once a year (...) , to screening every two years, or to a control group. Participants who were screened submitted six guaiac-impregnated paper slides with two smears from each of three consecutive stools. About 83 percent of the slides were rehydrated. Participants who tested positive underwent a diagnostic evaluation that included colonoscopy. Vital status was ascertained for all study participants during 13 years of follow-up. A committee determined causes of death. A single pathologist determined the stage of each tissue

1993 NEJM Controlled trial quality: uncertain

3514. Breast cancer screening with mammography: overview of Swedish randomised trials. (Abstract)

Breast cancer screening with mammography: overview of Swedish randomised trials. Despite encouraging results from screening trials the efficacy of mammography in reducing mortality remains somewhat controversial. Five studies have been done in Sweden. This overview, based on 282,777 women followed for 5-13 years in randomised trials in Malmö, Kopparberg, Ostergötland, Stockholm, and Gothenburg, reveals a 24% (95% confidence interval 13-34%) significant reduction of breast cancer mortality among (...) those invited to mammography screening compared with those not invited. To avoid the potential risk of differential misclassification causes of death were assessed by an independent end-point committee after a blinded review of all fatal breast cancer cases. The mortality reduction was similar, irrespective of the end-point used for evaluation ("breast cancer as underlying cause of death" or "breast cancer present at death"). There was a consistent risk reduction associated with screening in all

1993 Lancet Controlled trial quality: uncertain

3515. Effect of prenatal ultrasound screening on perinatal outcome. RADIUS Study Group. (Abstract)

Effect of prenatal ultrasound screening on perinatal outcome. RADIUS Study Group. Many clinicians advocate routine ultrasound screening during pregnancy to detect congenital anomalies, multiple-gestation pregnancies, fetal growth disorders, placental abnormalities, and errors in the estimation of gestational age. However, it is not known whether the detection of these conditions through screening leads to interventions that improve perinatal outcome.We conducted a randomized trial involving (...) 15,151 pregnant women at low risk for perinatal problems to determine whether ultrasound screening decreased the frequency of adverse perinatal outcomes. The women randomly assigned to the ultrasound-screening group underwent one sonographic examination at 15 to 22 weeks of gestation and another at 31 to 35 weeks. The women in the control group underwent ultrasonography only for medical indications, as identified by their physicians. Adverse perinatal outcome was defined as fetal death, neonatal

1993 NEJM Controlled trial quality: predicted high

3516. Screening for breast cancer in women aged 40-49 years

Screening for breast cancer in women aged 40-49 years Screening for breast cancer in women aged 40-49 years Screening for breast cancer in women aged 40-49 years Caro J J, O'Brien J Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Caro J J, O'Brien J. Screening for breast cancer in women aged 40-49 years. Montreal: Conseil d'Evaluation des (...) Technologies de la Sante du Quebec (CETS). 1993 Authors' objectives To review and analyze the evidence relating to possible health benefits, adverse effects and costs of periodic mammographic screening of women aged age 40 to 49 years, in the absence of any reasons for suspicion of breast cancer. Authors' conclusions Public policy involving the lives of thousands of individuals and large resources should not normally be made in the absence of either direct evidence of benefit or at least, extremely

1993 Health Technology Assessment (HTA) Database.

3517. Cholesterol screening and treatment

Cholesterol screening and treatment Cholesterol screening and treatment Cholesterol screening and treatment NHS Centre for Reviews and Dissemination Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NHS Centre for Reviews and Dissemination. Cholesterol screening and treatment. University of York. Effective Health Care 1(6). 1993 Authors (...) ' objectives To assess the role of cholesterol screening and cholesterol lowering treatment in reducing mortality from Coronary Heart Disease. Authors' conclusions Cholesterol screening is unlikely to make a contribution to the lowering of overall mortality and should be actively discouraged. Therapy should be targeted at those patients at highest overall CHD risk. Project page URL Indexing Status Subject indexing assigned by CRD MeSH Cholesterol; Hypercholesterolemia; Mass Screening Language Published

1993 Health Technology Assessment (HTA) Database.

3518. Recruitment methods for screening programmes: trial of an improved method within a regional osteoporosis study

Recruitment methods for screening programmes: trial of an improved method within a regional osteoporosis study Recruitment methods for screening programmes: trial of an improved method within a regional osteoporosis study Recruitment methods for screening programmes: trial of an improved method within a regional osteoporosis study Torgerson D J, Garton M J, Donaldson C, Russell I T, Reid D M Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Recruitment for screening for osteoporosis Type of intervention Screening Economic study type Cost-effectiveness analysis Study population Women aged 45-49 years Setting Osteoporosis screening unit (primary care). The economic study was carried out in Aberdeen, U. K. Dates to which

1993 NHS Economic Evaluation Database.

3519. An economic evaluation of screening for Chlamydia trachomatis in adolescent males

An economic evaluation of screening for Chlamydia trachomatis in adolescent males An economic evaluation of screening for Chlamydia trachomatis in adolescent males An economic evaluation of screening for Chlamydia trachomatis in adolescent males Genc M, Runsuvaara L, Mardh P A Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed (...) by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening for chlamydia trachomatis with a leukocyte esterase (LE) dipstick and enzyme immunoassay (EIA) on urine samples. Type of intervention Screening, treatment. Economic study type Cost-effectiveness analysis. Study population Adolescent males aged 15-19, military recruits or those at schooliversity, theoretical cohort of 1000. Setting Primary care routine health check centre. The economic

1993 NHS Economic Evaluation Database.

3520. Screening for abdominal aortic aneurysm in men aged 60 to 80 years: a cost-effectiveness analysis

Screening for abdominal aortic aneurysm in men aged 60 to 80 years: a cost-effectiveness analysis Screening for abdominal aortic aneurysm in men aged 60 to 80 years: a cost-effectiveness analysis Screening for abdominal aortic aneurysm in men aged 60 to 80 years: a cost-effectiveness analysis Frame P S, Fryback D G, Patterson C Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) in the USA. Dates to which data relate Effectiveness and cost data were mainly extracted from a review published in 1991. No price date was given. Source of effectiveness data Synthesis of previous studies. Modelling A simulation model was used to estimate costs and benefits. Outcomes assessed in the review Sensitivity and specificity of the screening procedures in detecting AAA. Study designs and other criteria for inclusion in the review Study design was not stated. The studies were published

1993 NHS Economic Evaluation Database.